Combination therapy with montelukast and loratadine alleviates pharyngolaryngeal symptoms related to seasonal allergic rhinitis

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1068-1070.e3. doi: 10.1016/j.jaip.2018.07.034. Epub 2018 Aug 10.

Authors

Yoshimasa Imoto¹, Tetsuji Takabayashi², Masafumi Sakashita², Takahiro Tokunaga², Taiyo Morikawa², Takahiro Ninomiya², Masayuki Okamoto², Norihiko Narita², Shigeharu Fujieda²

Affiliations

¹ Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. Electronic address: yimoto@u-fukui.ac.jp.
² Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

PMID: 30103031
DOI: 10.1016/j.jaip.2018.07.034

No abstract available

Publication types

Controlled Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Acetates / therapeutic use*
Adolescent
Adult
Allergens / immunology
Anti-Allergic Agents / therapeutic use*
Cryptomeria / immunology
Cyclopropanes
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Leukotriene Antagonists / therapeutic use*
Loratadine / therapeutic use*
Male
Middle Aged
Pollen / immunology
Quinolines / therapeutic use*
Rhinitis, Allergic, Seasonal / drug therapy*
Sulfides
Young Adult

Substances

Acetates
Allergens
Anti-Allergic Agents
Cyclopropanes
Leukotriene Antagonists
Quinolines
Sulfides
Loratadine
montelukast